MedTrace Logo

Treatment of BV With First Deqularum and Then Direkt After Clindamycin

NCT04067531 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-10-27

No results posted yet for this study

Summary

Treatment of BV with first deqularum cloride and then followed with clindamycin vaginal Cream.

Conditions

  • Infection, Bacterial

Interventions

DRUG

treatment of BV with first Deqularum and then direkt after with vaginal clindamycin

All patients will get the same treatment

Sponsors & Collaborators

  • Skaraborg Hospital

    lead OTHER_GOV

Principal Investigators

  • P-G Larsson · professor

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2021-08-01
Completion
2021-12-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04067531 on ClinicalTrials.gov